Clinical outcome of chemoradiotherapy in patients (pts) with limited-disease small-cell lung cancer (LD-SCLC) with ipsilateral pleural effusion

被引：1
|
作者：
Niho, S. [1 ]
Kubota, K. [1 ]
Yoh, K. [1 ]
Goto, K. [1 ]
Ohmatsu, H. [1 ]
Saijo, N. [1 ]
Nishiwaki, Y. [1 ]
机构：
[1] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion
    Niho, Seiji
    Kubota, Kaoru
    Yoh, Kiyotaka
    Goto, Koichi
    Ohmatsu, Hironobu
    Nihei, Keiji
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 723 - 727
  • [2] Prophylactic cranial irradiation (PCI) in limited-disease small-cell lung cancer (LD-SCLC) patients with brain imaging
    Mamesaya, Nobuaki
    Wakuda, Kazushige
    Kotake, Mie
    Fujiwara, Takumi
    Kobayashi, Haruki
    Kawamura, Takahisa
    Nakashima, Kazuhisa
    Omori, Shota
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Chemoradiotherapy in limited-disease small-cell lung cancer
    Fukuda, Minoru
    Ogawara, Daiki
    Nakamura, Yoichi
    Kohno, Shigeru
    LUNG CANCER MANAGEMENT, 2012, 1 (02) : 135 - 143
  • [4] Prognostic value of inflammation-based markers in limited disease small-cell lung cancer (LD-SCLC)
    Kaesmann, L.
    Bolm, L.
    Janssen, S.
    Rades, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S53 - S54
  • [5] Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer
    Niho, Seiji
    Fujii, Hirofumi
    Murakami, Koji
    Nagase, Seisuke
    Yoh, Kiyotaka
    Goto, Koichi
    Ohmatsu, Hironobu
    Kubota, Kaoru
    Sekiguchi, Ryuzo
    Nawano, Shigeru
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    LUNG CANCER, 2007, 57 (03) : 328 - 333
  • [6] Phase I study of amrubicin and cisplatin with concurrent thoracic radiotherapy (TRT) in limited-disease small cell lung cancer (LD-SCLC)
    Shimada, Midori
    Nakatomi, Katsumi
    Yamaguchi, Hiroyuki
    Dotsu, Yosuke
    Ikeda, Takaya
    Sugasaki, Nanae
    Yamazaki, Takuya
    Hayashi, Nobuyuki
    Nakamura, Yoichi
    Fukuda, Minoru
    Mukae, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Accelerated Hypofractionated Radiotherapy and Concurrent Etoposide / Cisplatin in Patients with Limited-Disease SCLC (LD-SCLC)
    Abdelwahab, Sherif
    Elghamry, Wesam
    Azmy, Ali
    Fouad, Iman
    Elsayed, Zeinab
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S626 - S626
  • [8] Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC)
    Gronberg, Bjorn H.
    Sundstrom, Stein H.
    Flotten, Oystein
    Brustugun, Odd Terje
    Brunsvig, Paal F.
    Bremnes, Roy M.
    Kaasa, Stein
    Halvorsen, Tarje O.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S744 - S744
  • [9] Clinical Significance of Downstaging in Patients With Limited-Disease Small-Cell Lung Cancer
    Go, Se-Il
    Keam, Bhumsuk
    Kim, Tae Min
    Lee, Se-Hoon
    Kim, Dong-Wan
    Kim, Hak Jae
    Wu, Hong-Gyun
    Chung, Doo Hyun
    Heo, Dae Seog
    CLINICAL LUNG CANCER, 2014, 15 (02) : E1 - E6
  • [10] External Validation of a Survival Score for Limited Disease Small Cell Lung Cancer (LD-SCLC)
    Kaesmann, L.
    Abdo, R.
    Eze, C.
    Dantes, M.
    Taugner, J.
    Gennen, K.
    Roengvoraphoj, O.
    Rades, D.
    Niyazi, M.
    Belka, C.
    Manapov, F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S750 - S750
12345